Publications dans lesquelles il/elle collabore avec VICTOR MANUEL BARBERA JUAN (20)

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  3. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

2019

  1. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

    International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483

2017

  1. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1618-1624

  2. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2013

  1. EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease

    Public Health Genomics, Vol. 16, Núm. 6, pp. 305-312

2010

  1. Biallelic MYH germline mutations as cause of Muir-Torre syndrome

    Familial Cancer, Vol. 9, Núm. 2, pp. 151-154

2009

  1. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: A case-control study

    BMC Cancer, Vol. 9

  2. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study

    BMC Cancer, Vol. 9

  3. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162

2006

  1. Molecular biology of exocrine pancreatic cancer

    Clinical and Translational Oncology, Vol. 8, Núm. 5, pp. 306-312

2005

  1. Biología molecular del cáncer de páncreas exocrino

    Revisiones en Cancer, Vol. 19, Núm. 1, pp. 12-26

  2. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines

    Molecular Cancer Therapeutics, Vol. 4, Núm. 8, pp. 1222-1230

2002

  1. Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: A variety of causes and a cascade of consequences

    Journal of Epidemiology and Community Health, Vol. 56, Núm. 10, pp. 734-738

2000

  1. Occupation and pancreatic cancer in Spain: A case-control study based on job titles

    International Journal of Epidemiology, Vol. 29, Núm. 6, pp. 1004-1013

  2. The 18q21 region in colorectal and pancreatic cancer: Independent loss of DCC and DPC4 expression

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, Núm. 2, pp. 283-296

1999

  1. Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records

    Digestive Diseases and Sciences, Vol. 44, Núm. 12, pp. 2469-2477